Insider Trading Alert - RCAP, SYNA And MMS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 18, 2014, 121 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $235.29 to $1,686,187,500.00.

Highlighted Stocks Traded by Insiders:

RCS Capital (RCAP) - FREE Research Report

Weil Edward M Jr., who is Ceo at RCS Capital, bought 20,550 shares at $12.14 on Nov. 18, 2014. Following this transaction, the Ceo owned 1.1 million shares meaning that the stake was boosted by 1.93% with the 20,550-share transaction.

The shares most recently traded at $12.30, up $0.16, or 1.32% since the insider transaction. Historical insider transactions for RCS Capital go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 5.0 million
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 5.0 million
  • 24-Week # shares bought: 6,457
  • 24-Week # shares sold: 5.0 million

The average volume for RCS Capital has been 1.2 million shares per day over the past 30 days. RCS Capital has a market cap of $795.7 million and is part of the financial sector and financial services industry. Shares are down 29.37% year-to-date as of the close of trading on Tuesday.

RCS Capital Corporation, through its subsidiaries, is engaged in the wholesale broker-dealer, and investment banking and capital markets business activities. The stock currently has a dividend yield of 3.01%. Currently, there are no analysts who rate RCS Capital a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on RCAP - FREE

TheStreet Quant Ratings rates RCS Capital as a sell. The company's weaknesses can be seen in multiple areas, such as its weak operating cash flow, poor profit margins and generally disappointing historical performance in the stock itself. Get the full RCS Capital Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Synaptics (SYNA) - FREE Research Report

Bergman Rick, who is President and CEO at Synaptics, sold 10,000 shares at $61.24 on Nov. 18, 2014. Following this transaction, the President and CEO owned 39,715 shares meaning that the stake was reduced by 20.11% with the 10,000-share transaction.

The shares most recently traded at $60.98, down $0.26, or 0.43% since the insider transaction. Historical insider transactions for Synaptics go as follows:

  • 4-Week # shares sold: 6,000
  • 12-Week # shares sold: 6,000
  • 24-Week # shares sold: 10,530

The average volume for Synaptics has been 1.0 million shares per day over the past 30 days. Synaptics has a market cap of $2.2 billion and is part of the technology sector and computer software & services industry. Shares are up 19.51% year-to-date as of the close of trading on Tuesday.

Synaptics Incorporated develops, markets, and sells custom-designed human interface solutions for electronic devices and products primarily in China, South Korea, Taiwan, the United States, Japan, and other countries. The company has a P/E ratio of 64.2. Currently, there are 9 analysts who rate Synaptics a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on SYNA - FREE

TheStreet Quant Ratings rates Synaptics as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Synaptics Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Maximus (MMS) - FREE Research Report

Lederer Paul R, who is Director at Maximus, sold 6,250 shares at $52.09 on Nov. 18, 2014. Following this transaction, the Director owned 85,873 shares meaning that the stake was reduced by 6.78% with the 6,250-share transaction.

Seymann Marilyn R, who is Director at Maximus, sold 2,806 shares at $52.55 on Nov. 18, 2014. Following this transaction, the Director owned 95,155 shares meaning that the stake was reduced by 2.86% with the 2,806-share transaction.

The shares most recently traded at $51.55, down $1.00, or 1.94% since the insider transaction. Historical insider transactions for Maximus go as follows:

  • 4-Week # shares bought: 245
  • 4-Week # shares sold: 58,080
  • 12-Week # shares bought: 245
  • 12-Week # shares sold: 64,692
  • 24-Week # shares bought: 245
  • 24-Week # shares sold: 98,110

The average volume for Maximus has been 372,600 shares per day over the past 30 days. Maximus has a market cap of $3.5 billion and is part of the services sector and diversified services industry. Shares are up 18.37% year-to-date as of the close of trading on Tuesday.

MAXIMUS, Inc. provides business process services to government health and human services agencies in the United States, Australia, Canada, the United Kingdom, and Saudi Arabia. The company operates in two segments, Health Services and Human Services. The stock currently has a dividend yield of 0.35%. The company has a P/E ratio of 24.6. Currently, there are 4 analysts who rate Maximus a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MMS - FREE

TheStreet Quant Ratings rates Maximus as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income, good cash flow from operations, growth in earnings per share and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Maximus Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Steel and Aluminum Stocks Suffer Amidst Trade War Woes

Steel and Aluminum Stocks Suffer Amidst Trade War Woes

Dow Tumbles as Trump Ratchets Up China Trade Fight

Dow Tumbles as Trump Ratchets Up China Trade Fight

FANG Stocks Get Swept Up in Broader Market Selloff

FANG Stocks Get Swept Up in Broader Market Selloff

Snap Shares Plunge After Cowen Cuts Price Target

Snap Shares Plunge After Cowen Cuts Price Target

Jim Cramer: Aramark Is a Great Company but It's Levered to Baseball

Jim Cramer: Aramark Is a Great Company but It's Levered to Baseball